UnitedHealth Group Incorporated $UNH Shares Sold by Texas Bank & Trust Co

Texas Bank & Trust Co trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,442 shares of the healthcare conglomerate’s stock after selling 160 shares during the period. Texas Bank & Trust Co’s holdings in UnitedHealth Group were worth $1,279,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Citizens National Bank Trust Department lifted its stake in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after buying an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares during the period. Caitlin John LLC lifted its stake in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares during the period. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at $515,000. Finally, Full Sail Capital LLC lifted its position in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.28% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on UNH shares. TD Securities restated a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating for the company in a research report on Wednesday, August 20th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a research report on Wednesday, July 16th. Raymond James Financial downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Finally, UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $353.00.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $309.77 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $280.55 billion, a P/E ratio of 13.42, a PEG ratio of 1.95 and a beta of 0.43. The company has a 50 day moving average price of $288.16 and a 200 day moving average price of $381.70. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the business earned $6.80 EPS. The business’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.